With only 12% 1 of therapies surviving the gauntlet of Phase III trials to receive FDA approval, and the cost to bring a drug ...

The approach can be transformative. When patients feel heard and understood, they’re more likely to engage actively and ...

If approved, the six manufacturers – Dr Reddy’s Laboratories Limited, Emcure, Eva Pharma, Ferozsons Laboratories Limited, ...

HALIX, a Dutch contract development and manufacturing organisation (CDMO) specialising in complex therapeutic antibodies and ...

A new report commissioned by the Association of the British Pharmaceutical Industry (ABPI) has found that hospitals engaging ...

During pilot programmes, Concentriq Embeddings demonstrated its ability to significantly accelerate AI development. In one ...

With a three-decade-plus journey in the oncology space, Hevia and Sousa spoke to the company’s developments in lung, bladder, and colorectal cancer, as announced at both ESMO and WCLC, as well as what ...

Starting January 1, 2025, most Blue Shield commercial members using Fresenius Kabi's adalimumab-aacf (a Humira biosimilar) ...

In the third, final, and by most reckonings most inconsequential, national debate of the US presidential election, vice ...

The lawsuit, originally filed by the Roofers Local No. 149 Pension Fund in 2023, alleges that Amgen misled shareholders by ...

Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the ...

Seven new clinical trial grants were awarded under the Orphan Product Grants Program during the fiscal year (FY) 2024, ...